This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Buller, A. L. Articles by Penning, T. M. Search for Related Content PubMed PubMed Citation Articles by Buller, A. L. Articles by Penning, T. M.

Characterization of Dihydrodiol Dehydrogenase in Rat H-4IIe Hepatoma Cells¹

Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6084

Dihydrodiol dehydrogenase (EC 1.3.1.20) catalyzes the NADP⁺-dependent oxidation of a variety of trans-dihydrodiol proximate carcinogens, a reaction that may suppress their carcinogenicity. Using benzenedihydrodiol [(+)-trans-1,2-dihydroxy-3,5-cyclohexadiene] as a substrate, this enzyme can be detected spectrophotometrically in rat H-4IIe hepatoma cells with a specific activity similar to that observed in rat liver cytosol. The hepatoma cell enzyme is potently inhibited by 6-medroxy-progesterone acetate (IC₅₀ = 38 nM) and indomethacin (IC₅₀ = 3.5 µM). These cells contain 3-hydroxysteroid dehydrogenase which is also sensitive to inhibition by the same two drugs. Chromatofocusing of hepatoma cell lysates indicates that both dihydrodiol dehydrogenase and 3-hydroxysteroid dehydrogenase activities coelute with a pI = 5.8. Western blot analysis of hepatoma cell lysates, using rabbit anti-rat 3-hydroxysteroid/dihydrodiol dehydrogenase serum detects a single immunoreactive species with a M_r 34,000. Using this antiserum it was possible to immunotitrate both these enzyme activities in H-4IIe lysates. Exposure of confluent cells to either 10 µM benz[a]anthracene or 10 µM dexamethasone, which are known inducers in H-4IIe cells of aryl-hydrocarbon hydroxylase and tyrosine aminotransferase respectively, failed to elevate dihydrodiol dehydrogenase activity. The following agents also failed to induce dihydrodiol dehydrogenase activity: phenobarbital, ethoxyquin, phenolic anti-oxidants, testosterone, estradiol-17ß, and growth hormone. Since the hepatoma cell enzyme has properties in common with the purified rat liver enzyme (which is identical to 3-hydroxysteroid dehydrogenase) including, M_r, pI, immunoreactivity, and sensitivity to drug inhibition, this cell line represents a useful system for studying the role of dihydrodiol dehydrogenase in the further metabolism of trans-dihydrodiols. Interestingly, the enzyme does not appear to be under the control of known inducers of phase I and phase II drug metabolizing enzymes.

¹ This research was supported by National Cancer Institute Grant CA 39504 and a Research Career Development Award K04 1335 awarded to T. M. P.

² To whom requests for reprints should be addressed, at Department of Pharmacology, University of Pennsylvania School of Medicine, 37th and Hamilton Walk, Philadelphia, PA 19104-6084.

Received 3/ 9/89. Revised 8/15/89. Accepted 9/18/89.